Antisense inhibition of miR-122, a liver specific microRNA, markedly improves hyperlipidemia, hepatic steatosis and hepatic function in ob/ob mice

被引：0
|
作者：
Murray, Susan F.
Booten, Sheri L.
Esau, Christine
Propp, Stephaine
Freier, Susan
Bennett, C. Frank
Bhanot, Sanjay
Gaarde, William A.
Monia, Brett P.
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A62 / A63
页数：2
相关论文
共 37 条
  • [11] Liver Grb14 Inhibition Restores Glucose Tolerance and Hepatic Insulin Signaling in ob/ob Mice
    Carre, Nadege
    Cauezac, Michele
    Postic, Catherine
    Girard, Jean
    Burnol, Anne-Francoise
    DIABETES, 2009, 58 : A339 - A339
  • [12] CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice
    Nassir, Fatiha
    Adewole, Okunade L.
    Brunt, Elizabeth M.
    Abumrad, Nada A.
    JOURNAL OF LIPID RESEARCH, 2013, 54 (11) : 2988 - 2997
  • [13] The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice
    Cossiga, Valentina
    Lembo, Vincenzo
    Nigro, Cecilia
    Mirra, Paola
    Miele, Claudia
    D'Argenio, Valeria
    Leone, Alessia
    Mazzone, Giovanna
    Veneruso, Iolanda
    Guido, Maria
    Beguinot, Francesco
    Caporaso, Nicola
    Morisco, Filomena
    NUTRIENTS, 2021, 13 (04)
  • [14] The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice
    Castoldi, Mirco
    Spasic, Maja Vujic
    Altamura, Sandro
    Elmen, Joacim
    Lindow, Morten
    Kiss, Judit
    Stolte, Jens
    Sparla, Richard
    D'Alessandro, Lorenza A.
    Klingmueller, Ursula
    Fleming, Robert E.
    Longerich, Thomas
    Groene, Hermann J.
    Benes, Vladimir
    Kauppinen, Sakari
    Hentze, Matthias W.
    Muckenthaler, Martina U.
    JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (04): : 1386 - 1396
  • [15] Inhibition of hepatic PEPCK (cytosolic) mRNA expression with an antisense oligonucleotide does not attenuate hyperglycemia in diabetic ob/ob and db/db mice
    Bhanot, S
    Murray, SF
    Booten, SL
    Mckay, RA
    Jacobs, SJ
    Michael, MD
    Nestorowicz, A
    Sloop, KW
    Monia, BP
    DIABETES, 2004, 53 : A574 - A574
  • [16] Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice
    Yu, XX
    Murray, SF
    Pandey, SK
    Booten, SL
    Bao, DJ
    Song, XZ
    Kelly, S
    Chen, SY
    McKay, R
    Monia, BP
    Bhanot, S
    HEPATOLOGY, 2005, 42 (02) : 362 - 371
  • [17] Administration of Apolipoprotein CIII Antisense Oligonucleotides to ob/ob Mice Reduces Hepatic ApocIII mRNA Expression and Plasma Triglyceride and Improves Glucose Tolerance
    Lee, Richard
    Fu, Wuxia
    Bell, Thomas A.
    Mullick, Adam E.
    Graham, Mark
    Crooke, Rosanne
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E290 - E290
  • [18] ALTERED HEPATIC ENERGY METABOLISM AND A LACK OF OBVIOUS ADVERSE FINDINGS AFTER MIR-122 INHIBITION IN MICE
    Esau, Christine
    Davis, Scott
    Li, Chuanyu
    Chang, Aaron
    Murray, James
    Capaldi, Roderick A.
    Marcusson, Eric
    Bhat, Balkrishen
    Newgard, Christopher
    Linsley, Peter
    HEPATOLOGY, 2010, 52 (04) : 1217A - 1217A
  • [19] Roflumilast ameliorates GAN diet-induced non-alcoholic fatty liver disease by reducing hepatic steatosis and fibrosis in ob/ob mice
    Wang, Bin
    Zhu, Xiaochan
    Yu, Siting
    Xue, Huan
    Deng, Lijiao
    Zhang, Yushan
    Zhang, Yi
    Liu, Yunfeng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 722
  • [20] Overexpression of SIRT1 in the Liver Deacetylates X-Box Binding Protein 1 and Attenuates Hepatic Steatosis and Insulin Resistance in ob/ob Mice
    Li, Yu
    Nakamura, Kazuto
    Kenneth, Walsh
    Zang, Mengwei
    DIABETES, 2011, 60 : A456 - A456
1234